Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19

NCT04493359 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Dificulteis in enrolling patients

Conditions

Covid19
Angiotensin II Receptor Antagonist Adverse Reaction

Interventions

DRUG: Renin-angiotensin system inhibitors

Sponsor

University of Sao Paulo